A class action lawsuit alleges Anavex Life Sciences misled investors about internal controls and regulatory risks tied to former CEO misconduct. Lead plaintiff deadline is November 30, 2026.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
